APO Research
Talk to an analyst

APO RESEARCH · REPORT

Esketamine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Esketamine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025183 pages

Choose your research edition.

Industry ResearchEsketamine Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Esketamine Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Esketamine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Esketamine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Esketamine Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Esketamine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Esketamine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Esketamine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Esketamine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Esketamine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Esketamine include Janssen Pharmaceutica, Merck, PFIZER, Medkoo and Endo International, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Esketamine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Esketamine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Esketamine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Esketamine market size, projected growth trends, production technologies, key applications, and end-use industries.

Esketamine Segment by Company

Janssen Pharmaceutica

Merck

PFIZER

Medkoo

Endo International

Esketamine Segment by Type

Injection

Oral Medications

Nasal Spray

Esketamine Segment by Application

General Anesthetic

Treatment-resistant Depression

Esketamine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Esketamine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Esketamine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Esketamine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Esketamine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Esketamine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Esketamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Esketamine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Esketamine Industry Trends Table 2. Esketamine Industry Drivers Table 3. Esketamine Industry Opportunities and Challenges Table 4. Esketamine Industry Restraints Table 5. Global Esketamine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Esketamine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Esketamine Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Esketamine Sales Market Share by Manufacturers Table 9. Global Esketamine Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Esketamine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Esketamine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Esketamine Manufacturers, Product Type & Application Table 13. Global Esketamine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Esketamine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Injection Table 17. Major Manufacturers of Oral Medications Table 18. Major Manufacturers of Nasal Spray Table 19. Global Esketamine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Esketamine Sales by Type (2021-2026) & (k units) Table 21. Global Esketamine Sales by Type (2027-2032) & (k units) Table 22. Global Esketamine Sales Market Share by Type (2021-2026) Table 23. Global Esketamine Sales Market Share by Type (2027-2032) Table 24. Global Esketamine Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Esketamine Revenue by Type (2021-2026) & (k units) Table 26. Global Esketamine Revenue by Type (2027-2032) & (k units) Table 27. Global Esketamine Revenue Market Share by Type (2021-2026) Table 28. Global Esketamine Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of General Anesthetic Table 30. Major Manufacturers of Treatment-resistant Depression Table 31. Global Esketamine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Esketamine Sales by Application (2021-2026) & (k units) Table 33. Global Esketamine Sales by Application (2027-2032) & (k units) Table 34. Global Esketamine Sales Market Share by Application (2021-2026) Table 35. Global Esketamine Sales Market Share by Application (2027-2032) Table 36. Global Esketamine Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Esketamine Revenue by Application (2021-2026) & (k units) Table 38. Global Esketamine Revenue by Application (2027-2032) & (k units) Table 39. Global Esketamine Revenue Market Share by Application (2021-2026) Table 40. Global Esketamine Revenue Market Share by Application (2027-2032) Table 41. Global Esketamine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Esketamine Sales by Region (2021-2026) & (k units) Table 43. Global Esketamine Sales Market Share by Region (2021-2026) Table 44. Global Esketamine Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Esketamine Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Esketamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Esketamine Sales by Country (2021-2026) & (k units) Table 48. North America Esketamine Sales by Country (2027-2032) & (k units) Table 49. Europe Esketamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Esketamine Sales by Country (2021-2026) & (k units) Table 51. Europe Esketamine Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Esketamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Esketamine Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Esketamine Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Esketamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Esketamine Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Esketamine Sales by Country (2027-2032) & (k units) Table 58. Global Esketamine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Esketamine Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Esketamine Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Esketamine Revenue Market Share by Region (2021-2026) Table 62. Global Esketamine Revenue Market Share by Region (2027-2032) Table 63. Janssen Pharmaceutica Company Information Table 64. Janssen Pharmaceutica Business Overview Table 65. Janssen Pharmaceutica Esketamine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Janssen Pharmaceutica Esketamine Product Portfolio Table 67. Janssen Pharmaceutica Recent Development Table 68. Merck Company Information Table 69. Merck Business Overview Table 70. Merck Esketamine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Merck Esketamine Product Portfolio Table 72. Merck Recent Development Table 73. PFIZER Company Information Table 74. PFIZER Business Overview Table 75. PFIZER Esketamine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. PFIZER Esketamine Product Portfolio Table 77. PFIZER Recent Development Table 78. Medkoo Company Information Table 79. Medkoo Business Overview Table 80. Medkoo Esketamine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Medkoo Esketamine Product Portfolio Table 82. Medkoo Recent Development Table 83. Endo International Company Information Table 84. Endo International Business Overview Table 85. Endo International Esketamine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Endo International Esketamine Product Portfolio Table 87. Endo International Recent Development Table 88. Key Raw Materials Table 89. Raw Materials Key Suppliers Table 90. Esketamine Distributors List Table 91. Esketamine Customers List Table 92. Research Programs/Design for This Report Table 93. Authors List of This Report Table 94. Secondary Sources Table 95. Primary Sources List of Figures Figure 1. Esketamine Product Image Figure 2. Global Esketamine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Esketamine Market Size (2021-2032) & (US$ Million) Figure 4. Global Esketamine Sales (2021-2032) & (k units) Figure 5. Global Esketamine Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Esketamine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Injection Image Figure 9. Oral Medications Image Figure 10. Nasal Spray Image Figure 11. Global Esketamine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Esketamine Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Esketamine Sales Market Share by Type (2021-2032) Figure 14. Global Esketamine Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Esketamine Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Esketamine Revenue Market Share by Type (2021-2032) Figure 17. General Anesthetic Image Figure 18. Treatment-resistant Depression Image Figure 19. Global Esketamine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Esketamine Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Esketamine Sales Market Share by Application (2021-2032) Figure 22. Global Esketamine Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Esketamine Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Esketamine Revenue Market Share by Application (2021-2032) Figure 25. North America Esketamine Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Esketamine Sales Market Share by Country (2021-2032) Figure 27. U.S. Esketamine Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Esketamine Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Esketamine Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Esketamine Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Esketamine Sales Market Share by Country (2021-2032) Figure 32. Germany Esketamine Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Esketamine Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Esketamine Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Esketamine Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Esketamine Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Esketamine Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Esketamine Sales Market Share by Country (2021-2032) Figure 39. China Esketamine Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Esketamine Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Esketamine Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Esketamine Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Esketamine Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Esketamine Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Esketamine Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Esketamine Sales Market Share by Country (2021-2032) Figure 47. Brazil Esketamine Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Esketamine Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Esketamine Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Esketamine Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Esketamine Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Esketamine Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Esketamine Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Esketamine Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Esketamine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Esketamine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Esketamine Revenue (2021-2032) & (US$ Million) Figure 58. North America Esketamine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Esketamine Revenue (2021-2032) & (US$ Million) Figure 60. Europe Esketamine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Esketamine Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Esketamine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Esketamine Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Esketamine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Esketamine Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Esketamine Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Oral Medications
  • Nasal Spray
Applications
  • General Anesthetic
  • Treatment-resistant Depression
Companies covered
  • Janssen Pharmaceutica
  • Merck
  • PFIZER
  • Medkoo
  • Endo International

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Esketamine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Esketamine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Esketamine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Esketamine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Esketamine Market Dynamics
  1. 2.1 Esketamine Industry Trends
  2. 2.2 Esketamine Industry Drivers
  3. 2.3 Esketamine Industry Opportunities and Challenges
  4. 2.4 Esketamine Industry Restraints
3 Esketamine Market by Manufacturers
  1. 3.1 Global Esketamine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Esketamine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Esketamine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Esketamine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Esketamine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Esketamine Manufacturers, Product Type & Application
  7. 3.7 Global Esketamine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Esketamine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Esketamine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Esketamine Tier 1, Tier 2, and Tier 3
4 Esketamine Market by Type
  1. 4.1 Esketamine Type Introduction
  2. 4.1.1 Injection
  3. 4.1.2 Oral Medications
  4. 4.1.3 Nasal Spray
  5. 4.2 Global Esketamine Sales by Type
  6. 4.2.1 Global Esketamine Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Esketamine Sales by Type (2021-2032)
  8. 4.2.3 Global Esketamine Sales Market Share by Type (2021-2032)
  9. 4.3 Global Esketamine Revenue by Type
  10. 4.3.1 Global Esketamine Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Esketamine Revenue by Type (2021-2032)
  12. 4.3.3 Global Esketamine Revenue Market Share by Type (2021-2032)
5 Esketamine Market by Application
  1. 5.1 Esketamine Application Introduction
  2. 5.1.1 General Anesthetic
  3. 5.1.2 Treatment-resistant Depression
  4. 5.2 Global Esketamine Sales by Application
  5. 5.2.1 Global Esketamine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Esketamine Sales by Application (2021-2032)
  7. 5.2.3 Global Esketamine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Esketamine Revenue by Application
  9. 5.3.1 Global Esketamine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Esketamine Revenue by Application (2021-2032)
  11. 5.3.3 Global Esketamine Revenue Market Share by Application (2021-2032)
6 Global Esketamine Sales by Region
  1. 6.1 Global Esketamine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Esketamine Sales by Region (2021-2032)
  3. 6.2.1 Global Esketamine Sales by Region (2021-2026)
  4. 6.2.2 Global Esketamine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Esketamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Esketamine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Esketamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Esketamine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Esketamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Esketamine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Esketamine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Esketamine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Esketamine Revenue by Region
  1. 7.1 Global Esketamine Revenue by Region
  2. 7.1.1 Global Esketamine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Esketamine Revenue by Region (2021-2026)
  4. 7.1.3 Global Esketamine Revenue by Region (2027-2032)
  5. 7.1.4 Global Esketamine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Esketamine Revenue (2021-2032)
  8. 7.2.2 North America Esketamine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Esketamine Revenue (2021-2032)
  11. 7.3.2 Europe Esketamine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Esketamine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Esketamine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Esketamine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Esketamine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Janssen Pharmaceutica
  2. 8.1.1 Janssen Pharmaceutica Company Information
  3. 8.1.2 Janssen Pharmaceutica Business Overview
  4. 8.1.3 Janssen Pharmaceutica Esketamine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Janssen Pharmaceutica Esketamine Product Portfolio
  6. 8.1.5 Janssen Pharmaceutica Recent Developments
  7. 8.2 Merck
  8. 8.2.1 Merck Company Information
  9. 8.2.2 Merck Business Overview
  10. 8.2.3 Merck Esketamine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck Esketamine Product Portfolio
  12. 8.2.5 Merck Recent Developments
  13. 8.3 PFIZER
  14. 8.3.1 PFIZER Company Information
  15. 8.3.2 PFIZER Business Overview
  16. 8.3.3 PFIZER Esketamine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 PFIZER Esketamine Product Portfolio
  18. 8.3.5 PFIZER Recent Developments
  19. 8.4 Medkoo
  20. 8.4.1 Medkoo Company Information
  21. 8.4.2 Medkoo Business Overview
  22. 8.4.3 Medkoo Esketamine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Medkoo Esketamine Product Portfolio
  24. 8.4.5 Medkoo Recent Developments
  25. 8.5 Endo International
  26. 8.5.1 Endo International Company Information
  27. 8.5.2 Endo International Business Overview
  28. 8.5.3 Endo International Esketamine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Endo International Esketamine Product Portfolio
  30. 8.5.5 Endo International Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Esketamine Value Chain Analysis
  2. 9.1.1 Esketamine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Esketamine Production Mode & Process
  6. 9.2 Esketamine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Esketamine Distributors
  9. 9.2.3 Esketamine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst